Using low-dose octreotide with diazoxide-resistant congenital hyperinsulinism resulting from compound heterozygous mutations in the ABCC8 gene

Ann Pediatr Endocrinol Metab. 2023 Dec;28(Suppl 1):S23-S24. doi: 10.6065/apem.2244068.034. Epub 2022 Jun 29.
No abstract available